| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Gustave Roussy [Automatic translation follows] Prevention / Care / Research / Education, at the service of patients with #cancer. Gustave Roussy, the leading cancer center in Europe, the 4th best cancer hospital in the world, is a global center of expertise against cancer, at the service of patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Greater Paris). A private institution of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and education Sectors: | 427 | 343 | 72 |
 | AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: | 3755 | 2597 | 203 |
 | L'Usine Digitale [Automatic translation follows] The media of digital transformation L’Usine Digitale (www.usine-digitale.fr) is THE media of the digital transformation of the economy. Every day, the editorial team unearths technological innovations and new business models that will transform the economy of tomorrow. It also deciphers the best practices of companies (large groups, SMEs, start-ups, etc.), all sectors combined, and analyzes the underlying trends in high tech. | 704 | 411 | 293 |
 | Le Figaro [Automatic translation follows] Le Figaro, the culture of freedom since 1826, the leading general daily newspaper and the most visited news site in France. With an audience of over 9 million unique visitors (source: Médiamétrie/NetRatings), the site is characterized by the quality and depth of its content, the result of the complementarity between its paper editorial teams (daily and magazines) and its web editorial team; by its Internet 2.0 uses and the importance of video, which has become a central element of the content offering. Lefigaro.fr also bases its development on the synergies built with the other sites of the … Sectors: | 3840 | 3499 | 239 |
 | WILCO [Automatic translation follows] Liberator of ambitions that helps women and men realize their innovative transformation projects. Challenger. Disrupter. Transform Create economic value. Positively impact society. This is what drives the WILCO teams. startups, honor loan, innovation, fundraising, Open Innovation, FrenchTech, Digital, Healthcare, Industry, Health, Fundraising, Acceleration, ETI, Large Groups, Corporate, and Intrapreneurship | 618 | 146 | 538 |
 | MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: | 2099 | 1849 | 189 |
 | Europe 1 [Automatic translation follows] Europe 1, the radio that informs and entertains you every day Europe 1 is a private generalist radio station belonging to the Lagardère group. Created in 1955, it offers both information and entertainment, it is the radio of the event. Find us also on www.europe1.fr, faceboook, twitter and Instagram. https://www.europe1.fr/emissions/la-france-bouge Radio, Journalism, Information, Entertainment, Programs, and News | 1037 | 890 | 107 |
 | Pierre Fabre Laboratories New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: | 738 | 547 | 146 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3444 | 2570 | 830 |
 | 中外製薬 / Chugai Pharmaceutical Co., Ltd. [Automatic translation follows] Chugai Pharmaceutical (headquarters: Tokyo) is a research and development-based pharmaceutical company with strengths in its unique drug discovery technology platform, including antibody engineering technology. As an important member of the Roche Group and a listed company on the Tokyo Stock Exchange Prime Market, Chugai is committed to creating innovative medicines that meet unmet medical needs under an independent management system. Please refer to our Social Media Policy for use: https://www.chugai-pharm.co.jp/rule/sns/index.html Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai … Sectors: | 5 | 3 | 0 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 812 | 481 | 491 |
 | Ministère de la Santé [Automatic translation follows] Official account of the Ministry of Health and Access to Care The Ministry of Health and Access to Care prepares and implements the Government's policy in the areas of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity | 1156 | 887 | 147 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1542 | 1407 | 58 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: | 799 | 615 | 69 |
 | Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: | 1747 | 1555 | 121 |
Health